Enhanced response of granulosa and theca cells from sheep carriers of the FecB mutation in vitro to gonadotropins and bone morphogenic protein-2, -4, and -6.
Campbell. B K BK; Souza. C J H CJ; Skinner. A J AJ; Webb. R R; Baird. D T DT
Key Findings
- BMPs increase estradiol output from granulosa cells when IGF‑1 LR3 is present
- Low BMP doses promote theca cell growth while high doses suppress androgen production
- Cells from FecB‑mutant sheep make 4‑5× more hormones than normal cells under the same stimulation
Practical Outcomes
- While the data show IGF‑1 LR3 can amplify BMP‑driven hormone effects in ovary cells, the work is in sheep and tied to a unique genetic mutation, so it doesn’t translate into actionable dosing or protocols for human longevity, metabolism, or performance.
Summary
The study looked at sheep ovarian cells and found that the IGF‑1 LR3 analog works together with bone‑morphogenetic proteins (BMP‑2,‑4,‑6) to boost hormone production, especially in sheep with a specific FecB mutation. These results are specific to sheep ovaries and don’t give clear guidance for human use.
Abstract
The FecB (Booroola) mutation, which leads to increased ovulation rates and multiple births in sheep, is now known to occur in the signaling domain of the bone morphogenic protein (BMP)-1B receptor. We examined the effect of the mutation on the responsiveness of granulosa (GC) and theca cells (TC) to BMPs and other local regulators using tissue from animals with (Fec(B/B)) and without (Fec(+/+)) the FecB mutation. Experiments examined the effect of BMP-2, -4, and -6 (0.005-50 ng/ml), and their interaction with IGF-I (0.1-10 ng/ml LR3 analog) and gonadotropins, on the proliferation and differentiation of GCs and TCs isolated from small (<2 mm) antral follicles and maintained in serum-free culture for up to 8 d. Dose-finding studies using ovaries from wild-type sheep obtained from the abbattoir showed no difference among the different BMPs in stimulating (P < 0.001) estradiol (E2) production by GCs cultured with FSH (10 ng/ml), but there was a clear interaction (P < 0.001) with IGF-I. BMPs had no effect on GC proliferation or the sensitivity of GCs to FSH. In contrast, higher doses of BMPs (5-50 ng/ml) inhibited LH-stimulated androstenedione production by TCs, whereas lower doses (0.005-0.05 ng/ml) stimulated TC proliferation (P < 0.01). Regardless of dose of IGF-I, at the end of culture (96-192 h) hormone production by GCs (E2, inhibin A) and TCs (androstenedione) was 4- to 5-fold greater (P < 0.001) by cells from Fec(B/B), compared with Fec(+/+) ewes exposed to the same dose of gonadotropin. In the presence of low concentrations of IGF-I (0.1 ng/ml), the maximum increase in the production of E2 and inhibin A by GCs from FF ewes in response to BMPs was observed at doses that were 3- to 10-fold lower (3-10 ng/ml) than ++ (30 ng/ml; P < 0.001). Low doses of BMPs stimulated proliferation of TCs from ++ (P < 0.01) but not FF ewes. Immunohistochemistry confirmed BMP-6 protein expression in the oocyte, granulosa, and thecal layers of antral follicles from both genotypes. These results confirm a major role for BMPs in controlling ovarian somatic cell function in sheep and provide evidence to support the hypothesis that the FecB mutation increases the BMP response of somatic cells when stimulated to differentiate by gonadotropins.
Study Information
pubmed
2006
2006-01-05T00:00:00.000Z
10.1210/en.2005-0604